Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intestinal Fistula | 1 | 2021 | 47 | 0.790 |
Why?
|
| Skin Ulcer | 1 | 2021 | 72 | 0.780 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 259 | 0.770 |
Why?
|
| Virtual Reality | 1 | 2018 | 36 | 0.620 |
Why?
|
| Crohn Disease | 1 | 2021 | 334 | 0.610 |
Why?
|
| Preceptorship | 1 | 2018 | 44 | 0.610 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 349 | 0.610 |
Why?
|
| Manikins | 1 | 2018 | 137 | 0.580 |
Why?
|
| Biological Products | 1 | 2021 | 316 | 0.570 |
Why?
|
| Proton Pump Inhibitors | 1 | 2019 | 272 | 0.560 |
Why?
|
| Teaching | 1 | 2018 | 252 | 0.550 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2018 | 372 | 0.520 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2017 | 356 | 0.520 |
Why?
|
| Esophageal and Gastric Varices | 1 | 2016 | 94 | 0.520 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2016 | 330 | 0.470 |
Why?
|
| Cost of Illness | 1 | 2017 | 505 | 0.450 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2024 | 3393 | 0.420 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 876 | 0.420 |
Why?
|
| Liver Cirrhosis | 2 | 2016 | 1033 | 0.410 |
Why?
|
| Caregivers | 1 | 2017 | 739 | 0.360 |
Why?
|
| Colonoscopy | 3 | 2015 | 523 | 0.270 |
Why?
|
| Colonic Polyps | 2 | 2015 | 221 | 0.200 |
Why?
|
| Biological Factors | 1 | 2021 | 50 | 0.180 |
Why?
|
| Infliximab | 1 | 2021 | 140 | 0.180 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2020 | 85 | 0.170 |
Why?
|
| Adenoma | 2 | 2015 | 745 | 0.170 |
Why?
|
| Drug Monitoring | 1 | 2021 | 356 | 0.160 |
Why?
|
| Barrett Esophagus | 1 | 2024 | 561 | 0.160 |
Why?
|
| Precancerous Conditions | 2 | 2015 | 1065 | 0.150 |
Why?
|
| Nadolol | 1 | 2016 | 37 | 0.140 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2017 | 89 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 2679 | 0.130 |
Why?
|
| Propranolol | 1 | 2016 | 160 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 4399 | 0.130 |
Why?
|
| Ascites | 1 | 2016 | 216 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 1614 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2016 | 243 | 0.120 |
Why?
|
| Mortality | 1 | 2016 | 354 | 0.120 |
Why?
|
| Proctoscopy | 1 | 2013 | 18 | 0.120 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 559 | 0.110 |
Why?
|
| Intestinal Polyps | 1 | 2013 | 75 | 0.110 |
Why?
|
| Heart Rate | 1 | 2016 | 761 | 0.110 |
Why?
|
| Adenomatous Polyps | 1 | 2013 | 45 | 0.110 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 489 | 0.110 |
Why?
|
| Comorbidity | 2 | 2016 | 2439 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 531 | 0.110 |
Why?
|
| Humans | 13 | 2024 | 271941 | 0.110 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2016 | 678 | 0.100 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 604 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 469 | 0.090 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 5118 | 0.090 |
Why?
|
| Tuberculosis | 1 | 2017 | 614 | 0.090 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 3240 | 0.090 |
Why?
|
| Age Factors | 2 | 2016 | 5521 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2017 | 1039 | 0.090 |
Why?
|
| Colorectal Neoplasms | 2 | 2015 | 3704 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 5105 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2174 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 1443 | 0.060 |
Why?
|
| Rectal Neoplasms | 1 | 2013 | 1240 | 0.060 |
Why?
|
| Optical Fibers | 1 | 2024 | 39 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2016 | 6883 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2016 | 9494 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2024 | 33874 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4811 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 5195 | 0.050 |
Why?
|
| United States | 2 | 2016 | 16053 | 0.050 |
Why?
|
| Cholagogues and Choleretics | 1 | 2020 | 38 | 0.050 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 55 | 0.050 |
Why?
|
| Risk Factors | 1 | 2016 | 18047 | 0.040 |
Why?
|
| Middle Aged | 4 | 2017 | 90427 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 1707 | 0.040 |
Why?
|
| Proctoscopes | 1 | 2013 | 2 | 0.030 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 186 | 0.030 |
Why?
|
| Male | 4 | 2017 | 128995 | 0.030 |
Why?
|
| Colonoscopes | 1 | 2013 | 24 | 0.030 |
Why?
|
| Adult | 2 | 2017 | 81889 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2016 | 39800 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 787 | 0.030 |
Why?
|
| Aged | 2 | 2016 | 73494 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2013 | 124 | 0.030 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 145 | 0.030 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 600 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 633 | 0.030 |
Why?
|
| Microscopy | 1 | 2013 | 193 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2013 | 581 | 0.020 |
Why?
|
| Video Recording | 1 | 2013 | 280 | 0.020 |
Why?
|
| Female | 3 | 2017 | 149187 | 0.020 |
Why?
|
| Sex Factors | 1 | 2016 | 2206 | 0.020 |
Why?
|
| Observer Variation | 1 | 2013 | 720 | 0.020 |
Why?
|
| Rectum | 1 | 2013 | 479 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 782 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2013 | 555 | 0.020 |
Why?
|
| Colon | 1 | 2013 | 691 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 4352 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 946 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 6236 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 1076 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 1060 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 2538 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 1125 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 1340 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1624 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 4998 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 4891 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12533 | 0.010 |
Why?
|
| Heart Failure | 1 | 2016 | 2500 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 13402 | 0.010 |
Why?
|